GlassScriptPhysician profile
Sean Edward Dunleavy
NPI 1285021725
$4,206.36
in general payments reported to CMS, 2019-2025
16 companies · $44.22 in 2025
The $44.22 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,460 · 2020: $1,237 · 2021: $431 · 2023: $34.77 · 2025: $44.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,606.05 | 2019-2020 | |
| Organogenesis INC. | $472.04 | 2019-2021 | |
| Stryker Corporation | $302.06 | 2019-2021 | |
| Djo, LLC | $206.44 | 2019-2020 | |
| Orthofix Medical, INC. | $135.15 | 2019 | |
| Horizon Therapeutics Plc | $120.24 | 2019-2021 | |
| Crossroads Extremity Systems, LLC | $119.76 | 2019 | |
| Cardiovascular Systems INC. | $76.72 | 2019 | |
| Smith+Nephew, INC. | $29.39 | 2020 | |
| Bioventus LLC | $26.62 | 2025 | Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $23.59 | 2019 | |
| Medtronic Vascular, INC. | $22.44 | 2020 | |
| Abbvie INC. | $19.35 | 2023 | Dalvance |
| Alaska Medical Technologies, LLC | $17.60 | 2025 | |
| Paratek Pharmaceuticals, INC. | $15.42 | 2023 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $13.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Dunleavy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.